Diligence memo · auto-generated · as of July 2, 2026
Maximum Fidelity Surgical Simulations, Inc.
Maximum Fidelity Surgical Simulations, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Maximum Fidelity Surgical Simulations, Inc. operates in Biotechnology, based in ST. LOUIS.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Maximum Fidelity Surgical Simulations, Inc. has raised $2.2M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.2M on 2024-06-17.
Most recent recorded round closed around 2024-06-17.
Valuation (modeled)modeled
Provath models Maximum Fidelity Surgical Simulations, Inc. at approximately $11M (range $1.6M–$30M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.78× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era. Within the normal band (78% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2.0 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 29% of Biotechnology peers (4293 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.